PureTech Health (PTCHF) Stock Price, News & Analysis

Company Overview

PureTech Health is a clinical-stage biotherapeutics company focused on discovering and developing medicines to address a range of chronic and life-threatening diseases. The company leverages a patient-centric approach and proprietary insights to identify novel targets and advance therapeutic candidates across areas such as immunology, oncology, neuroscience and gastrointestinal disorders. PureTech’s model emphasizes de-risking early programs through rigorous translational validation before advancing into clinical development.

Rather than operating as a traditional research organization, PureTech Health builds and nurtures a portfolio of subsidiary companies, each dedicated to a specific therapeutic approach or platform technology. Notable portfolio companies include those developing treatments for neuropsychiatric conditions, metabolic diseases, and immune-mediated disorders. This structure allows PureTech to apply focused expertise and resources to individual programs while retaining significant economic interests in each venture as they progress through the clinic and, potentially, into commercialisation.

Founded in 2005 and headquartered in both Boston and London, PureTech Health pursues a global development strategy with collaborations and research partnerships spanning North America and Europe. The company was established by Dr. Daphne Zohar, who continues to lead the organization as Chief Executive Officer. Under her leadership, PureTech has built a diversified pipeline and aims to deliver transformative therapies by combining scientific rigor with an entrepreneurial, spin-out model of innovation.

Key Stats

• Today's Range: $1.71 to $1.71
• 50-Day Range: $1.65 to $1.76
• 52-Week Range: $1.27 to $2.28
• Volume: N/A
• Average Volume: 8,168 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PTCHF Stock Analysis - Frequently Asked Questions

How have PTCHF shares performed this year?

PureTech Health's stock was trading at $2.00 at the start of the year. Since then, PTCHF shares have decreased by 14.5% and is now trading at $1.71.

How do I buy shares of PureTech Health?

Shares of PTCHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/20/2025
• Next Earnings (Estimated): 8/26/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:PTCHF
• CIK: 1782999
• Web: www.puretechhealth.com
• Phone: (617) 482-2333
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A